CombinedError

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

BioSig Technologies 

NASDAQ

Free

BioSig Technologies 's Price discount from 1 year high of 59.34% is great compared to market average of 21.38%. This indicates BSGM could be a good value stock.

Price discount from 1 year high vs Market

BSGM has concerning Price-to-book ratio (FQ) of 36.58 which is 5.94x higher than market average. Meaning that BSGM could be overvalued.

Price-to-book ratio (FQ) vs Market

Value

Quality

Ownership

Growth

Dividends

is a comprehensive guide for investors seeking income investments. It helps discover stocks with attractive dividend yield trends and growth potential based on historical data.

empowers investors by providing accurate growth forecasts and indicators, enabling them to make proactive choices and build winning portfolios.

reveals confidence through institutional and insider holdings, which help investors understand the dynamics of stock ownership.

assesses a company's operational efficiency, financial health, stability, and growth potential, aiding investment decisions.

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

helps identify undervalued stocks based on fundamentals, ideal for value investors like Warren Buffett.

Performance History

Score Breakdown

Welcome to Stocklytics

Analyst Forecast

Analyst Ratings

BioSig Technologies (BSGM)

Keep an eye on BioSig Technologies

Take Your Investments to a Whole New Level